AbbVie Inc.

Total Valuation

AbbVie Inc. carries a market capitalization of 453.27B, placing it among publicly traded companies globally. Its enterprise value stands at 514.02B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

AbbVie Inc. currently has 1.77B shares outstanding.

Valuation Ratios

AbbVie Inc. trades at a trailing price-to-earnings ratio of 71.35. The price-to-sales ratio is 6.99, and the price-to-book ratio stands at -75.77.

Enterprise Valuation

On an enterprise value basis, AbbVie Inc. trades at an EV/EBITDA multiple of 17.30 and an EV/FCF ratio of 22.43. The EV/Sales ratio of 7.98 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 23.52 provides insight into valuation relative to core operating earnings.

Financial Position

AbbVie Inc. maintains a current ratio of 0.81, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,202.82, indicating conservative leverage, while an interest coverage ratio of 10.19 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, AbbVie Inc. has paid 2.38B in income taxes, reflecting an effective tax rate of 27.39.

Stock Price Statistics

AbbVie Inc.'s stock has gained approximately 23.49543% over the past 52 weeks. The 50-day moving average sits at 245.48, while the 200-day moving average is 226.05.

Income Statement

Over the trailing twelve months, AbbVie Inc. generated 64.39B in revenue and converted that into 6.31B in net income, yielding earnings per share of 3.56. EBITDA reached 29.72B, while operating income came in at 21.85B.

Balance Sheet

AbbVie Inc. holds 6.57B in cash and equivalents against 70.82B in total debt, resulting in a net debt position of 64.25B. Total book value stands at -5.93B, with working capital of -7.97B providing operational flexibility.

Cash Flow

AbbVie Inc. produced 19.51B in operating cash flow over the past twelve months. After subtracting -1.30B in capital expenditures, free cash flow totaled 18.21B - equivalent to 10.29 per share.

Margins

AbbVie Inc. operates with a gross margin of 71.48, reflecting its pricing power and cost economics. The operating margin of 33.94 and net profit margin of 9.80 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 189.47 indicates the proportion of earnings distributed to shareholders.

Scores

AbbVie Inc. posts an Altman Z-Score of 3.95, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.